US Stock MarketDetailed Quotes

REPL Replimune

Watchlist
  • 12.550
  • +0.330+2.70%
Close Dec 13 16:00 ET
  • 12.550
  • 0.0000.00%
Post 16:20 ET
945.52MMarket Cap-4.13P/E (TTM)

Replimune Key Stats

Replimune Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Replimune Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 9, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data